BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
2.77
-0.15 (-4.97%)
At close: Jun 13, 2025, 3:59 PM
2.76
-0.28%
After-hours: Jun 13, 2025, 04:00 PM EDT

Revenue by Geography

Period Ending Dec 31, 2024
Indonesia Revenue 138.3K
Indonesia Revenue Growth n/a
Singapore Revenue 572.03K
Singapore Revenue Growth n/a
Sri Lanka Revenue 459K
Sri Lanka Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Selling, General, and Administrative Revenue -148.82K 469.4K 2.13M 759.66K 625.77K -15.91K 3.08M 807.08K 536.87K 487.86K 418.82K 434.12K 345.24K 161.21K 362.31K 378.05K 302.85K 1.17M 70.66K 58.18K 38.85K 135.83K 63.1K 81.22K 76.49K 58.42K 79.03K 67.89K 36.59K 123.44K
Selling, General, and Administrative Revenue Growth -131.70% -77.96% +180.35% +21.40% -4033.42% -100.52% +281.76% +50.33% +10.05% +16.48% -3.52% +25.74% +114.15% -55.50% -4.16% +24.83% -74.01% +1549.15% +21.44% +49.78% -71.40% +115.27% -22.32% +6.19% +30.93% -26.07% +16.40% +85.56% -70.36% n/a
Research and Development Revenue 12.14K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a